Mirum Pharmaceuticals Inc. (MIRM) NASDAQ

$13.41 -0.91 (-6.35%)

Market Cap: $410.86M

As of 11/26/21 01:00 PM EST. Market closed.

(MIRM)

Mirum Pharmaceuticals Inc. (MIRM) NASDAQ

$13.41 -0.91 (-6.35%)

Market Cap: $410.86M

As of 11/26/21 01:00 PM EST. Market closed.

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Mirum's lead product candidate, maralixibat, is an investigational oral drug in development for Alagille syndrome (ALGS), progressive familial intrahepatic cholestasis (PFIC), and biliary atresia. ... read more

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Mirum's lead product candidate, maralixibat, is an investigational oral drug in development for Alagille syndrome (ALGS), progressive familial intrahepatic cholestasis (PFIC), and biliary atresia. Mirum has submitted an NDA for maralixibat in the treatment of cholestatic pruritus in patients with ALGS. Additionally, Mirum's marketing authorization application for the treatment of pediatric patients with PFIC2 has been accepted for review (validated) by the European Medicines Agency. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
68
Address
.
KEY STATS
Open
$13.49
Previous Close
$14.32
Days Range
$13.38 - $14.25
52 week range
$13.38 - $26.31
Volume
64,772
Avg. Volume (30 days)
134,516
Market Cap
$410.86M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
30,638,194
Open
$13.49
Previous Close
$14.32
Days Range
$13.38 - $14.25
52 week range
$13.38 - $26.31
Volume
64,772
Avg. Volume (30 days)
134,516
Market Cap
$410.86M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
30,638,194

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR MIRUM PHARMACEUTICALS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Vig Pamela Chief Scientific Officer Nov 10, 2021 Option Exercise $13.52 768 10,380 10,435 Nov 15, 2021, 04:26 PM
Tucker Edwin Jonathan Chief Medical Officer Nov 10, 2021 Option Exercise $13.52 70 946 45,838 Nov 15, 2021, 04:23 PM
Radovich Peter Chief Operating Officer Nov 10, 2021 Option Exercise $13.52 958 12,947 12,231 Nov 15, 2021, 04:21 PM
Longpre Lara Chief Development Officer Nov 10, 2021 Option Exercise $13.52 753 10,177 84,998 Nov 15, 2021, 04:19 PM
Clements Ian Chief Financial Officer Nov 10, 2021 Option Exercise $13.52 458 6,190 17,111 Nov 15, 2021, 04:16 PM
Peetz Christopher President and CEO Oct 01, 2021 Sale $19.26 3,672 70,708 21,027 Oct 01, 2021, 08:00 PM
Vig Pamela Chief Scientific Officer Oct 01, 2021 Sale $19.26 1,364 26,265 9,667 Oct 01, 2021, 08:00 PM
Clements Ian Chief Financial Officer Oct 01, 2021 Sale $19.26 1,574 30,309 16,653 Oct 01, 2021, 08:00 PM
Longpre Lara Chief Development Officer Oct 01, 2021 Sale $19.26 961 18,505 84,245 Oct 01, 2021, 08:00 PM
Radovich Peter Chief Operating Officer Oct 01, 2021 Sale $19.26 1,364 26,265 11,273 Oct 01, 2021, 08:00 PM
Tucker Edwin Jonathan Chief Medical Officer Oct 01, 2021 Sale $19.26 1,364 26,265 45,768 Oct 01, 2021, 08:00 PM
Flynn James E 10% Owner Jul 09, 2021 Sale $15.81 99,325 1,570,328 0 Jul 13, 2021, 12:06 PM
Flynn James E 10% Owner Jul 06, 2021 Sale $16.19 49,239 797,426 106,162 Jul 07, 2021, 06:48 PM
Flynn James E 10% Owner Jul 02, 2021 Sale $17.01 10,599 180,300 155,401 Jul 07, 2021, 06:48 PM
Flynn James E 10% Owner Jul 07, 2021 Sale $15.87 6,837 108,496 99,325 Jul 07, 2021, 06:48 PM
Tucker Edwin Jonathan Chief Medical Officer May 10, 2021 Option Exercise $14.62 1,483 21,681 39,007 May 12, 2021, 05:46 PM
Radovich Peter Chief Operating Officer May 10, 2021 Option Exercise $14.62 1,006 14,708 4,512 May 12, 2021, 05:45 PM
Peetz Christopher President and CEO May 10, 2021 Option Exercise $14.62 1,453 21,243 2,824 May 12, 2021, 05:41 PM
Longpre Lara Chief Development Officer May 10, 2021 Option Exercise $14.62 1,259 18,407 77,081 May 12, 2021, 05:38 PM
Clements Ian Chief Financial Officer Dec 23, 2020 Buy $18.65 1,592 29,691 7,871 Mar 08, 2021, 07:42 PM
Tucker Edwin Jonathan Chief Medical Officer Mar 05, 2021 Option Exercise $7.70 1,082 8,331 37,524 Mar 08, 2021, 06:40 PM
Tucker Edwin Jonathan Chief Medical Officer Dec 28, 2020 Option Exercise $7.70 4,167 32,086 36,442 Dec 29, 2020, 04:24 PM
Clements Ian Chief Financial Officer Dec 23, 2020 Buy $18.61 2,470 45,975 7,841 Dec 28, 2020, 04:12 PM
Peetz Christopher President and CEO Dec 23, 2020 Buy $18.70 5,000 93,480 201,570 Dec 28, 2020, 04:06 PM
Vig Pamela Chief Scientific Officer Nov 10, 2020 Option Exercise $15.27 595 9,083 2,207 Nov 12, 2020, 05:20 PM
Radovich Peter Chief Operating Officer Nov 10, 2020 Option Exercise $15.27 861 13,144 3,506 Nov 12, 2020, 05:16 PM
Longpre Lara Chief Development Officer Nov 10, 2020 Option Exercise $15.27 822 12,549 75,822 Nov 12, 2020, 05:14 PM
Tucker Edwin Jonathan Chief Medical Officer Nov 10, 2020 Option Exercise $15.27 1,275 19,464 32,275 Nov 12, 2020, 05:12 PM
Clements Ian Chief Financial Officer Nov 10, 2020 Option Exercise $15.27 1,371 20,930 5,371 Nov 12, 2020, 05:06 PM
Peetz Christopher President and CEO Nov 10, 2020 Option Exercise $15.27 1,371 20,930 1,371 Nov 12, 2020, 05:03 PM
Tucker Edwin Jonathan Chief Medical Officer Oct 30, 2020 Option Exercise $7.70 25,000 192,500 31,000 Nov 03, 2020, 05:09 PM
Tucker Edwin Jonathan Chief Medical Officer Mar 20, 2020 Buy $11.90 2,500 29,740 6,000 Mar 23, 2020, 04:47 PM
Tucker Edwin Jonathan Chief Medical Officer Mar 19, 2020 Buy $9.91 2,000 19,818 3,500 Mar 23, 2020, 04:47 PM
Fischer Laurent Director Sep 17, 2019 Buy $9.37 1,648 15,435 6,750 Sep 18, 2019, 05:23 PM
Fischer Laurent Director Sep 16, 2019 Buy $9.47 452 4,280 5,102 Sep 18, 2019, 05:23 PM
Brege Laura Director Sep 10, 2019 Buy $11.22 10,000 112,200 10,000 Sep 12, 2019, 04:21 PM
Clements Ian SVP Finance & Communications Sep 06, 2019 Buy $11.51 4,000 46,039 4,000 Sep 10, 2019, 07:19 PM
Vig Pamela Chief Scientific Officer Sep 06, 2019 Buy $10.97 1,612 17,682 1,612 Sep 10, 2019, 07:17 PM
Peetz Christopher President and CEO Sep 09, 2019 Buy $11.14 4,320 48,132 196,570 Sep 10, 2019, 07:11 PM
Peetz Christopher President and CEO Sep 06, 2019 Buy $10.91 4,750 51,806 192,250 Sep 10, 2019, 07:11 PM
Fischer Laurent Director Sep 09, 2019 Buy $10.66 1,970 20,992 3,690 Sep 10, 2019, 07:10 PM
Fischer Laurent Director Sep 06, 2019 Buy $10.71 1,720 18,429 1,720 Sep 10, 2019, 07:10 PM
Fischer Laurent Director Sep 10, 2019 Buy $10.29 960 9,881 4,650 Sep 10, 2019, 07:10 PM
Walker Paul Edward 10% Owner Jul 22, 2019 Buy $15.00 450,000 6,750,000 4,186,243 Jul 24, 2019, 04:57 PM
Sonsini Peter W. 10% Owner Jul 22, 2019 Buy $15.00 450,000 6,750,000 4,186,243 Jul 24, 2019, 04:56 PM
SANDELL SCOTT D 10% Owner Jul 22, 2019 Buy $15.00 450,000 6,750,000 4,186,243 Jul 24, 2019, 04:56 PM
MOTT DAVID M 10% Owner Jul 22, 2019 Buy $15.00 450,000 6,750,000 4,186,243 Jul 24, 2019, 04:55 PM
MAKOWER JOSHUA 10% Owner Jul 22, 2019 Buy $15.00 450,000 6,750,000 4,186,243 Jul 24, 2019, 04:55 PM
Makhzoumi Mohamad 10% Owner Jul 22, 2019 Buy $15.00 450,000 6,750,000 4,186,243 Jul 24, 2019, 04:54 PM
Florence Anthony A. Jr. 10% Owner Jul 22, 2019 Buy $15.00 450,000 6,750,000 4,186,243 Jul 24, 2019, 04:54 PM
Chang Carmen 10% Owner Jul 22, 2019 Buy $15.00 450,000 6,750,000 4,186,243 Jul 24, 2019, 04:53 PM
Behbahani Ali 10% Owner Jul 22, 2019 Buy $15.00 450,000 6,750,000 4,186,243 Jul 24, 2019, 04:53 PM
BASKETT FOREST 10% Owner Jul 22, 2019 Buy $15.00 450,000 6,750,000 4,186,243 Jul 24, 2019, 04:52 PM
BARRIS PETER J 10% Owner Jul 22, 2019 Buy $15.00 450,000 6,750,000 4,186,243 Jul 24, 2019, 04:52 PM
New Enterprise Associates 16, L.P. 10% Owner Jul 22, 2019 Buy $15.00 450,000 6,750,000 4,186,243 Jul 24, 2019, 04:51 PM
Frazier Life Sciences IX, L.P. 10% Owner Jul 22, 2019 Buy $15.00 450,000 6,750,000 3,566,912 Jul 24, 2019, 04:17 PM
O'Donnell Niall Director Jul 22, 2019 Buy $15.00 300,000 4,500,000 1,921,118 Jul 24, 2019, 04:16 PM
Heron Patrick J Director Jul 22, 2019 Buy $15.00 450,000 6,750,000 3,566,912 Jul 24, 2019, 04:12 PM
Flynn James E 10% Owner Jul 22, 2019 Buy $15.00 166,000 2,490,000 166,000 Jul 24, 2019, 02:18 PM
Flynn James E 10% Owner Jul 22, 2019 Buy $15.00 166,000 2,490,000 1,724,456 Jul 24, 2019, 02:18 PM
Novo Holdings A/S 10% Owner Jul 22, 2019 Buy $15.00 575,000 8,625,000 2,445,147 Jul 23, 2019, 04:32 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Vig Pamela Chief Scientific Officer 11/10/2021 10,380
Tucker Edwin Jonathan Chief Medical Officer 11/10/2021 946
Radovich Peter Chief Operating Officer 11/10/2021 12,947
Longpre Lara Chief Development Officer 11/10/2021 10,177
Clements Ian Chief Financial Officer 11/10/2021 6,190
Peetz Christopher President and CEO 10/01/2021 70,708
Vig Pamela Chief Scientific Officer 10/01/2021 26,265
Clements Ian Chief Financial Officer 10/01/2021 30,309
Longpre Lara Chief Development Officer 10/01/2021 18,505
Radovich Peter Chief Operating Officer 10/01/2021 26,265
Tucker Edwin Jonathan Chief Medical Officer 10/01/2021 26,265
Flynn James E 10% Owner 07/09/2021 1,570,328
Flynn James E 10% Owner 07/06/2021 797,426
Flynn James E 10% Owner 07/02/2021 180,300
Flynn James E 10% Owner 07/07/2021 108,496
Tucker Edwin Jonathan Chief Medical Officer 05/10/2021 21,681
Radovich Peter Chief Operating Officer 05/10/2021 14,708
Peetz Christopher President and CEO 05/10/2021 21,243
Longpre Lara Chief Development Officer 05/10/2021 18,407
Clements Ian Chief Financial Officer 12/23/2020 29,691
Tucker Edwin Jonathan Chief Medical Officer 03/05/2021 8,331
Tucker Edwin Jonathan Chief Medical Officer 12/28/2020 32,086
Clements Ian Chief Financial Officer 12/23/2020 45,975
Peetz Christopher President and CEO 12/23/2020 93,480
Vig Pamela Chief Scientific Officer 11/10/2020 9,083
Radovich Peter Chief Operating Officer 11/10/2020 13,144
Longpre Lara Chief Development Officer 11/10/2020 12,549
Tucker Edwin Jonathan Chief Medical Officer 11/10/2020 19,464
Clements Ian Chief Financial Officer 11/10/2020 20,930
Peetz Christopher President and CEO 11/10/2020 20,930
Tucker Edwin Jonathan Chief Medical Officer 10/30/2020 192,500
Tucker Edwin Jonathan Chief Medical Officer 03/20/2020 29,740
Tucker Edwin Jonathan Chief Medical Officer 03/19/2020 19,818
Fischer Laurent Director 09/17/2019 15,435
Fischer Laurent Director 09/16/2019 4,280
Brege Laura Director 09/10/2019 112,200
Clements Ian SVP Finance & Communications 09/06/2019 46,039
Vig Pamela Chief Scientific Officer 09/06/2019 17,682
Peetz Christopher President and CEO 09/09/2019 48,132
Peetz Christopher President and CEO 09/06/2019 51,806
Fischer Laurent Director 09/09/2019 20,992
Fischer Laurent Director 09/06/2019 18,429
Fischer Laurent Director 09/10/2019 9,881
Walker Paul Edward 10% Owner 07/22/2019 6,750,000
Sonsini Peter W. 10% Owner 07/22/2019 6,750,000
SANDELL SCOTT D 10% Owner 07/22/2019 6,750,000
MOTT DAVID M 10% Owner 07/22/2019 6,750,000
MAKOWER JOSHUA 10% Owner 07/22/2019 6,750,000
Makhzoumi Mohamad 10% Owner 07/22/2019 6,750,000
Florence Anthony A. Jr. 10% Owner 07/22/2019 6,750,000
Chang Carmen 10% Owner 07/22/2019 6,750,000
Behbahani Ali 10% Owner 07/22/2019 6,750,000
BASKETT FOREST 10% Owner 07/22/2019 6,750,000
BARRIS PETER J 10% Owner 07/22/2019 6,750,000
New Enterprise Associates 16, L.P. 10% Owner 07/22/2019 6,750,000
Frazier Life Sciences IX, L.P. 10% Owner 07/22/2019 6,750,000
O'Donnell Niall Director 07/22/2019 4,500,000
Heron Patrick J Director 07/22/2019 6,750,000
Flynn James E 10% Owner 07/22/2019 2,490,000
Flynn James E 10% Owner 07/22/2019 2,490,000
Novo Holdings A/S 10% Owner 07/22/2019 8,625,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
0.20%
1Q
09/30/2021
03/31/2021
0.48%
2Q
09/30/2021
12/31/2020
19.79%
3Q
09/30/2021
09/30/2020
21.17%
4Q
09/30/2021
06/30/2020
21.58%
5Q
Load More

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
0.20%
1Q
03/31/2021
0.48%
2Q
12/31/2020
19.79%
3Q
09/30/2020
21.17%
4Q
06/30/2020
21.58%
5Q
Load More